You are in the accessibility menu

Statistics

Total Visits

Views
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 276

Total Visits per Month

May 2026 June 2026 July 2026 August 2026 September 2026 October 2026 November 2026
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 9 5 3 7 2 0 0

File Downloads

Views

Top Country Views

Views
United States 109
Brazil 34
Germany 24
China 16
Vietnam 13
Russia 8
Ukraine 7
United Kingdom 6
Japan 4
Turkey 4

Top City Views

Views
San Mateo 18
Ashburn 17
Hanoi 10
Fairfield 7
San Jose 7
Cambridge 6
Jacksonville 5
Tokyo 4
Seattle 3
Falls Church 2